Laxmi Dental Limited Share Price
Equities
LAXMIDENTL
INE0WO601020
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 241.30 INR | +1.45% |
|
-3.38% | -11.43% |
| Capitalization | 1.33TCr 15Cr 13Cr 12Cr 11Cr 20Cr 22Cr 135.39Cr 53Cr 634.03Cr 55Cr 54Cr 2.33TCr | P/E ratio 2026 * |
31.6x | P/E ratio 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.22TCr 14Cr 12Cr 11Cr 10Cr 19Cr 20Cr 124.98Cr 49Cr 585.27Cr 51Cr 50Cr 2.15TCr | EV / Sales 2026 * |
4.17x | EV / Sales 2027 * | 3.26x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.45% | ||
| 1 week | -3.38% | ||
| Current month | -11.43% | ||
| 1 month | -9.78% | ||
| 3 months | -24.66% | ||
| 6 months | -48.35% | ||
| Current year | -11.43% |
| 1 week | 236.9 | 251.55 | |
| 1 month | 236.9 | 288 | |
| Current year | 236.9 | 276.2 | |
| 1 year | 236.9 | 584 | |
| 3 years | 236.9 | 584 | |
| 5 years | 236.9 | 584 | |
| 10 years | 236.9 | 584 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 43 | 08/07/2004 | |
Arun B. John
SAM | Sales & Marketing | - | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 20/07/2024 | |
| Chairman | 56 | 01/01/1989 | |
| Director/Board Member | 43 | 08/07/2004 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.45% | -3.38% | - | - | 14Cr | ||
| +0.20% | -1.23% | -4.92% | +41.58% | 14TCr | ||
| 0.00% | +9,713.20% | +11,985.17% | +10,616.15% | 1.41TCr | ||
| -1.68% | +0.22% | -15.78% | -66.42% | 643.92Cr | ||
| +4.17% | +5.24% | -24.07% | +141.98% | 657.19Cr | ||
| +0.75% | -.--% | -.--% | +9.40% | 362.77Cr | ||
| -1.14% | +1.60% | +43.63% | +36.68% | 296.99Cr | ||
| -0.48% | -2.13% | -44.61% | -62.34% | 280.31Cr | ||
| -2.65% | +1.78% | +4.89% | -12.97% | 229.54Cr | ||
| Average | +0.08% | -1.48% | +1,493.04% | +1,338.01% | 1.97TCr | |
| Weighted average by Cap. | +0.21% | -1.29% | +946.37% | +877.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293.73Cr 3.25Cr 2.8Cr 2.61Cr 2.43Cr 4.52Cr 4.85Cr 30Cr 12Cr 140.42Cr 12Cr 12Cr 515.16Cr | 367.65Cr 4.07Cr 3.51Cr 3.27Cr 3.04Cr 5.65Cr 6.06Cr 38Cr 15Cr 175.76Cr 15Cr 15Cr 644.79Cr |
| Net income | 42Cr 46.49L 40.04L 37.32L 34.72L 64.58L 69.28L 4.29Cr 1.69Cr 20Cr 1.74Cr 1.71Cr 74Cr | 59Cr 65.08L 56.06L 52.24L 48.6L 90.42L 96.99L 6Cr 2.36Cr 28Cr 2.44Cr 2.39Cr 103.12Cr |
| Net Debt | -102Cr -1.13Cr -97.25L -90.63L -84.31L -1.57Cr -1.68Cr -10Cr -4.1Cr -49Cr -4.23Cr -4.15Cr -178.89Cr | -127.2Cr -1.41Cr -1.21Cr -1.13Cr -1.05Cr -1.96Cr -2.1Cr -13Cr -5.11Cr -61Cr -5.28Cr -5.17Cr -223.09Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 241.30 ₹ | +1.45% | 48,751 |
| 14/26/14 | 237.85 ₹ | -2.50% | 68,166 |
| 13/26/13 | 243.95 ₹ | -0.25% | 39,558 |
| 12/26/12 | 244.55 ₹ | -0.79% | 69,536 |
| 09/26/09 | 246.50 ₹ | -1.30% | 70,121 |
Delayed Quote NSE India S.E., January 16, 2026 at 03:42 pm IST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LAXMIDENTL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















